Home / Business and Economy / Pharma Firm Reports Rs 17.43 Cr Loss Amid Sales Surge
Pharma Firm Reports Rs 17.43 Cr Loss Amid Sales Surge
6 Feb
Summary
- Net loss of Rs 17.43 crore in December 2025 quarter.
- Sales increased by 16.21% to Rs 349.00 crore.
- Previous year's December quarter reported a profit of Rs 8.09 crore.
Solara Active Pharma Sciences experienced a notable shift in its financial performance during the quarter ending December 2025. The company reported a net loss of Rs 17.43 crore, a significant turnaround from the Rs 8.09 crore net profit recorded in the corresponding quarter of the previous year, December 2024.
Despite the bottom-line decline, the company's top-line performance showed considerable strength. Sales for the December 2025 quarter surged by 16.21% to Rs 349.00 crore. This marks an increase from the Rs 300.31 crore in sales achieved during the December 2024 quarter.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
